Zyprexa Marketing Goes "Back to Basics"

Lilly strategy will focus on identifying patients, promoting new indications/formulations and preserving access. Company acknowledges that combating negative safety impression for the antipsychotic is "not an easy task."

More from Archive

More from Pink Sheet